These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. [Werdnig-Hoffmann's congenital spinal atrophy in nursing infants]. Kutafin IuF; Osipov SM; Osipov ES Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(3):15-8. PubMed ID: 1646528 [TBL] [Abstract][Full Text] [Related]
66. Neuroblastoma in a Patient With Spinal Muscular Atrophy Type I: Is It Just a Coincidence? Sag E; Sen HS; Haliloglu G; Yalcin B; Kutluk T J Child Neurol; 2015 Jul; 30(8):1075-8. PubMed ID: 25123529 [TBL] [Abstract][Full Text] [Related]
69. Spinal Muscular Atrophy Type III Recognized After Delayed Recovery From Neuromuscular Blockade After an Orthognathic Surgery. Oda A; Oue K; Yoshida M J Craniofac Surg; 2023 Sep; 34(6):e580-e582. PubMed ID: 37253240 [TBL] [Abstract][Full Text] [Related]
70. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann disease. Baumgartner MR; Verhoeven NM; Jakobs C; Roels F; Espeel M; Martinez M; Rabier D; Wanders RJ; Saudubray JM Neurology; 1998 Nov; 51(5):1427-32. PubMed ID: 9818873 [TBL] [Abstract][Full Text] [Related]
71. Selective type II muscle fiber hypertrophy in severe infantile spinal muscular atrophy. Kingma DW; Feeback DL; Marks WA; Bobele GB; Leech RW; Brumback RA J Child Neurol; 1991 Oct; 6(4):329-34. PubMed ID: 1940135 [TBL] [Abstract][Full Text] [Related]
73. [Clinical and histochemical findings in spinal muscular atrophy]. Fukunaga H; Moritoyo T; Okubo R; Higuchi I; Osame M No To Shinkei; 1992 Jun; 44(6):547-52. PubMed ID: 1389561 [TBL] [Abstract][Full Text] [Related]
74. [Progressive spinal amyotrophy type I or Werdnig-Hoffman disease. Apropos of 5 cases in Dakar (Senegal)]. Ndiaye O; Sall G; Sylla A; Diouf S; Diagne I; Kuakuvi N Bull Soc Pathol Exot; 2002 Jun; 95(2):81-2. PubMed ID: 12145964 [TBL] [Abstract][Full Text] [Related]
75. Descriptive epidemiology of spinal muscular atrophy type I in Estonia. Vaidla E; Talvik I; Kulla A; Kahre T; Hamarik M; Napa A; Metsvaht T; Piirsoo A; Talvik T Neuroepidemiology; 2006; 27(3):164-8. PubMed ID: 17035693 [TBL] [Abstract][Full Text] [Related]
76. [Diagnostic progress in spinal muscular atrophy]. Gergont A; Kaciński M; Steczkowska-Klucznik M Przegl Lek; 2001; 58(11):989-91. PubMed ID: 11987841 [TBL] [Abstract][Full Text] [Related]
77. [Werdnig-Hoffmann amyotrophy in a 7-month-old child]. Kutafin IuF; Osipov SM Pediatriia; 1990; (4):91-3. PubMed ID: 2371136 [No Abstract] [Full Text] [Related]
78. Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1. Fitzgerald DA; Doumit M; Abel F Paediatr Respir Rev; 2018 Sep; 28():11-17. PubMed ID: 30414815 [TBL] [Abstract][Full Text] [Related]
79. Developmental and degenerative cardiac defects in the Taiwanese mouse model of severe spinal muscular atrophy. Maxwell GK; Szunyogova E; Shorrock HK; Gillingwater TH; Parson SH J Anat; 2018 Jun; 232(6):965-978. PubMed ID: 29473159 [TBL] [Abstract][Full Text] [Related]